miRNA General Information
miRNA Mature ID hsa-miR-495-3p
miRNA Stemloop AC MI0003135
miRNA Stemloop ID hsa-mir-495
Sequence aaacaaacauggugcacuucuu
TTD Target(s) Regulated by This miRNA Multidrug resistance protein 1 (ABCB1) Clinical trial Target Target Info [1]
RAC-alpha serine/threonine-protein kinase (AKT1) Successful Target Target Info [2]
Endoplasmic reticulum chaperone BiP (HSPA5) Clinical trial Target Target Info [3]
Monocyte chemotactic and activating factor (CCL2) Clinical trial Target Target Info [4]
Protein tyrosine phosphatase IVA 3 (PRL-3) Literature-reported Target Target Info [5]
Polycomb complex protein BMI-1 (BMI1) Clinical trial Target Target Info [6]
Runt-related transcription factor 3 (RUNX3) Literature-reported Target Target Info [7]
Forkhead box protein C1 (FOXC1) Literature-reported Target Target Info [8]
High mobility group protein HMGI-C (HMGA2) Literature-reported Target Target Info [9]
Protein(s) Regulated by This miRNA Copper-transporting ATPase 1 Regulated Protein [10]
Homeobox protein Meis1 Regulated Protein [11]
Metastasis-associated protein MTA3 Regulated Protein [12]
Pre-B-cell leukemia transcription factor 3 Regulated Protein [11]
S-adenosylmethionine synthase isoform type-1 Regulated Protein [13]
Submaxillary gland androgen-regulated protein 3B Regulated Protein [14]
TBC1 domain family member 9 Regulated Protein [15]
Transcription factor SOX-9 Regulated Protein [16]
References
REF 1 miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression. J Cell Mol Med. 2017 Sep;21(9):1929-1943.
REF 2 MiR-495 inhibits esophageal squamous cell carcinoma progression by targeting Akt1. Oncotarget. 2016 Aug 9;7(32):51223-51236.
REF 3 miR-199a-5p and miR-495 target GRP78 within UPR pathway of lung cancer. Gene. 2017 Jul 15;620:15-22.
REF 4 MicroRNA-495 regulates the proliferation and apoptosis of human umbilical vein endothelial cells by targeting chemokine CCL2. Thromb Res. 2015 Jan;135(1):146-54.
REF 5 miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3. Cancer Lett. 2012 Oct 1;323(1):41-7.
REF 6 MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network. J Biol Chem. 2012 Dec 14;287(51):42695-707.
REF 7 Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells. Oncotarget. 2015 Oct 20;6(32):33269-78.
REF 8 Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell. 2010 Apr 2;141(1):129-41.
REF 9 MicroRNA-495 Inhibits Gastric Cancer Cell Migration and Invasion Possibly via Targeting High Mobility Group AT-Hook 2 (HMGA2). Med Sci Monit. 2017 Feb 4;23:640-648.
REF 10 miR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting P-type adenosine triphosphatase A (ATP7A).J Cell Biochem. 2014 Jul;115(7):1234-42.
REF 11 MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia.Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19397-402.
REF 12 MiR-495 regulates proliferation and migration in NSCLC by targeting MTA3.Tumour Biol. 2014 Apr;35(4):3487-94.
REF 13 MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.J Clin Invest. 2013 Jan;123(1):285-98.
REF 14 Methylation-associated silencing of miR-495 inhibit the migration and invasion of human gastric cancer cells by directly targeting PRL-3.Biochem Biophys Res Commun. 2015 Jan 2;456(1):344-50.
REF 15 Changes in the expression of miR-381 and miR-495 are inversely associated with the expression of the MDR1 gene and development of multi-drug resistance.PLoS One. 2013 Nov 26;8(11):e82062.
REF 16 microRNA-495 inhibits chondrogenic differentiation in human mesenchymal stem cells by targeting Sox9.Stem Cells Dev. 2014 Aug 1;23(15):1798-808.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.